BDO’s annual Biotech Briefing examines the most recent 10-K SEC filings of companies listed on the NASDAQ Biotechnology Index. Join us as we analyze this year's findings and trends in the marketplace and specifically:
- Impacts of R&D spend
- Tax transformation as it relates to innovation
- Debt and equity financing in the life sciences industry
To view the recorded materials, please login or create an account.
Access the webinar recording
Note: CPE Credit is NOT available for the recording
For the latest business issues, insights and regulatory updates related to COVID-19, please visit our Resource Center